Bausch Health Companies Inc. Business Finance Contracts & Agreements

134 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Credit and Security Agreement among Bausch Receivables Funding LP, Bausch Health US, LLC, GLAS USA LLC, and Lenders
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2024
Stock and Asset Purchase Agreement among Novartis Pharma AG, Novartis Finance Corporation, and Bausch + Lomb Ireland Limited
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2023
Credit and Security Agreement among Bausch Receivables Funding LP, Bausch Health US, LLC, and Lenders (June 30, 2023)
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2023
Sixteenth Supplemental Indenture to 8.500% Senior Notes Due 2027 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 5.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 7.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fifteenth Supplemental Indenture to 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Sixteenth Supplemental Indenture to 9.250% Senior Notes Due 2026 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Amended and Restated Asset Purchase Agreement among Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc., and Bausch Health Ireland...
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2019
Indenture Agreement for $750,000,000 8.500% Senior Notes Due 2027 between Valeant Pharmaceuticals International and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2018
Indenture for $1,500,000,000 9.000% Senior Notes Due 2025 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2017
Indenture for Senior Notes Due 2020, 2023, and 2025 between VRX Escrow Corp. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Underwriting Agreement for $1,450,000,000 Common Shares between Valeant Pharmaceuticals International, Inc. and Deutsche Bank Securities Inc.
Underwriting Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Successor Agent Agreement and Amendment No. 9 to Third Amended and Restated Credit and Guaranty Agreement among Barclays Bank PLC, Goldman Sachs Lending Partners LLC, Valeant...
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for 5.50% Senior Notes Due 2023 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for 5.625% Senior Notes Due 2021 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 6.875% Senior Notes Due 2018 – Valeant Pharmaceuticals, Sanitas, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 6.75% Senior Notes Due 2021 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to July 2013 Indenture—Valeant Pharmaceuticals, Sanitas, and BNY Mellon Trust
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, Labenne Participações Ltda., Probiótica Laboratórios Ltda., and The Bank of...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Indenture for $998,937,000 9.000% Senior Secured Notes Due 2028 between 1375209 B.C. Ltd. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Indenture for Bausch Health Companies Inc. $351,533,000 14.000% Second Lien Secured Notes Due 2030
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for $1,774,067,000 11.00% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for $1,600,000,000 4.875% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2021
Indenture for $1,000,000,000 5.000% Senior Notes Due 2029 and $1,000,000,000 5.250% Senior Notes Due 2031 by Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Indenture for $1,500,000,000 6.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Indenture for $1,250,000,000 5.000% Senior Notes Due 2028 and $1,250,000,000 5.250% Senior Notes Due 2030 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Indenture for $750,000,000 7.000% Senior Notes Due 2028 and $750,000,000 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Form of Common Share Certificate of Bausch Health Companies Inc
Stock Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Interim Chief Executive Officer Employment Letter Agreement between Valeant Pharmaceuticals International, Inc. and Howard B. Schiller
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement – Valeant Pharmaceuticals, Barclays, and New Term Loan Lenders (April 1, 2015)
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals, Barclays Bank PLC, and New Term Loan Lenders (April 1, 2015)
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Supplemental Indenture to Assume and Guarantee Senior Notes among Valeant Pharmaceuticals, Guarantors, and Trustee (March 27, 2015)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals, New Term Loan Lenders, and Barclays Bank PLC
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement – Valeant Pharmaceuticals, Barclays Bank PLC, and New Revolving Loan Lenders
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015